Editorial: Clinical implementation of precision oncology data to direct individualized and immunotherapy-based treatment strategies
| dc.contributor.author | Young, Nicholas A. | |
| dc.contributor.author | Prosperi, Jenifer R. | |
| dc.contributor.author | Freud, Aharon G. | |
| dc.contributor.author | Yee, Nelson S. | |
| dc.contributor.author | Petricoin, Emanuel F. | |
| dc.contributor.department | Biochemistry and Molecular Biology, School of Medicine | |
| dc.date.accessioned | 2025-07-17T08:57:47Z | |
| dc.date.available | 2025-07-17T08:57:47Z | |
| dc.date.issued | 2025-06-13 | |
| dc.eprint.version | Final published version | |
| dc.identifier.citation | Young NA, Prosperi JR, Freud AG, Yee NS, Petricoin EF. Editorial: Clinical implementation of precision oncology data to direct individualized and immunotherapy-based treatment strategies. Front Immunol. 2025;16:1631591. Published 2025 Jun 13. doi:10.3389/fimmu.2025.1631591 | |
| dc.identifier.uri | https://hdl.handle.net/1805/49535 | |
| dc.language.iso | en_US | |
| dc.publisher | Frontiers Media | |
| dc.relation.isversionof | 10.3389/fimmu.2025.1631591 | |
| dc.relation.journal | Frontiers in Immunology | |
| dc.rights | Attribution 4.0 International | en |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
| dc.source | PMC | |
| dc.subject | Precision oncology | |
| dc.subject | Immunotherapy | |
| dc.subject | Individualized patient treatment | |
| dc.subject | Tumor-agnostic clinical/molecular testing | |
| dc.subject | Molecular profiling | |
| dc.subject | Next-generation sequencing (NGS) (DNAseq/RNAseq) | |
| dc.subject | Pan-omics | |
| dc.subject | Drug sensitivity testing | |
| dc.title | Editorial: Clinical implementation of precision oncology data to direct individualized and immunotherapy-based treatment strategies | |
| dc.type | Article |